Victoria Rutherford
Investor Relations, Medexis Pharmaceuticals
Replay available
Medexus Pharmaceuticals Inc. (MDP) Q4 2025 Earnings Call
Medexus Pharmaceuticals Inc. (TSX: MDP) Q4 2025 earnings conference call, held 2025-06-26. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Ken D'Entremont
Chief Executive Officer
Brendan Bushman
Chief Financial Officer
Andre Uden
Analyst, Research Capital
Michael Freeman
Analyst, Raymond James
David Martin
Analyst, Bloomberg
Scott Henry
Analyst, ADP
Unknown Participant
Analyst
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Medexus Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.238 Greetings. Welcome to the Medexis Pharmaceuticals fourth quarter and fiscal year-end 00:00:05.238 -- 00:00:06.941 2025 00:00:06.941 -- 00:00:12.288 conference call. At this time, all participants are in a listen-only mode. 00:00:12.288 -- 00:00:16.214 A question and answer session will follow the formal presentation. 00:00:16.214 -- 00:00:21.060 If anyone should require operator assistance during the conference, please press star 00:00:21.060 -- 00:00:26.127 zero on your telephone keypad. Please note this conference is being recorded. 00:00:26.127 -- 00:00:30.771 I will now turn the conference over to your host, Victoria Rutherford, Investor Relations 00:00:30.771 -- 00:00:32.593 of Medexis. 00:00:32.593 -- 00:00:33.214 You may begin. 00:00:33.214 -- 00:00:35.214 Thank 00:00:35.636 -- 00:00:40.662 you, and good morning, everyone. Welcome to the Medexis Pharmaceuticals fourth quarter 00:00:40.662 -- 00:00:45.907 and fiscal year 2025 earnings call. On the call this morning are Ken D'Entremont, Chief 00:00:45.907 -- 00:00:50.252 Executive Officer, and Brendan Bushman, Chief Financial Officer. 00:00:50.252 -- 00:00:54.517 If you have any questions after the conference call or would like further information 00:00:54.517 -- 00:00:59.964 about the company, please contact Adelaide Capital at 480- 625-5772. 00:00:59.964 -- 00:01:05.611 I would like to remind everyone that this discussion will include forward-looking 00:01:05.611 -- 00:01:10.517 information as defined in Canadian securities laws that is based on certain assumptions 00:01:10.517 -- 00:01:15.343 that Medexis believes to be reasonable in the circumstances but is subject to risks and 00:01:15.343 -- 00:01:16.825 uncertainties. 00:01:16.825 -- 00:01:21.771 Actual results may diff...